Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/1998
11/12/1998CA2289742A1 Method for generating activated t-cells and antigen-pulsed antigen-presenting cells
11/12/1998CA2289125A1 Potentiation of the immune response through delivery of compounds binding a cytoplasmic dipeptidase
11/12/1998CA2289124A1 Use of cd26 inhibitor for the manufacture of a medicament for the treatment of hiv
11/12/1998CA2289116A1 Enterococcus faecalis polynucleotides and polypeptides
11/12/1998CA2289110A1 Peptide analogues, and their uses in particular in pharmaceutical compositions and for diagnosis
11/12/1998CA2289025A1 Human serine protease precursor
11/12/1998CA2288944A1 Enterococcus faecalis polynucleotides and polypeptides
11/12/1998CA2288602A1 Use of a secretion vector for fertility control by oral vaccination
11/12/1998CA2288374A1 Intracellular production of hepatitis c e1 and e2 truncated polypeptides
11/12/1998CA2288232A1 Immunotoxins directed against malignant cells
11/12/1998CA2288129A1 Use of virus-like particles as adjuvants
11/12/1998CA2288017A1 Methods for eosinophil depletion and compositions therefor
11/11/1998EP0877086A2 Recombinant YF virus vaccines recovered from the infectious cDNA
11/11/1998EP0877085A1 OspA protein of borrelia burgdorferi subgroups, encoding genes and vaccines
11/11/1998EP0877083A1 A novel human G-protein coupled receptor (HCEPT09)
11/11/1998EP0877032A1 Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers
11/11/1998EP0877030A2 EPO primary response gene 1,(EPRG1)
11/11/1998EP0876614A1 Method of predicting resistance to hepatitis c infection
11/11/1998EP0876613A1 Treatment and diagnosis of infections due to helicobacter pylori
11/11/1998EP0876612A1 Method for identifying sex specific and species specific molecules, molecules identified using the method, and uses of the molecules
11/11/1998EP0876498A1 Mixture of recombinant vaccinia vectors as polygeur vaccines for hiv
11/11/1998EP0876487A1 Mammalian cx 3?c chemokine genes
11/11/1998EP0876486A2 Murine monoclonal anti-idiotype antibody 11d10 an methods of use thereof
11/11/1998EP0876485A2 NOVEL CREBa ISOFORM
11/11/1998EP0876483A1 Nucleic acids and proteins related to alzheimer's disease, and uses therefor
11/11/1998EP0876482A1 Il-13 receptor polypeptide
11/11/1998EP0876476A1 Heterophil-adapted poultry vaccine
11/11/1998EP0876398A1 Induction of immune response against desired determinants
11/11/1998EP0876397A1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof
11/11/1998EP0876157A1 Methods and compositions for passive immunotherapy
11/11/1998EP0876156A1 Compositions and methods for administering borrelia burgdorferi antigens
11/11/1998EP0876153A2 Medical use of proteases
11/11/1998EP0876150A1 Non-toxic mutants of pathogenic gram-negative bacteria
11/11/1998EP0744940B1 Drugs, vaccines and hormones in polylactide coated microspheres
11/11/1998EP0701604B1 Immortalization of denditric cells with v-myc oncogene
11/11/1998EP0659086B1 Novel bacterial vaccines using vaccine strains of pathogenic bacteria
11/11/1998CN1198674A Vaccines
11/10/1998US5834594 Polyethylene-protein conjugates
11/10/1998US5834592 Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
11/10/1998US5834591 Polypeptides and antibodies useful for the diagnosis and treatment of pathogenic neisseria and other microorganisms having type 4 pilin
11/10/1998US5834587 G-protein coupled receptor, HLTEX 11
11/10/1998US5834429 Inhibiting binding of a hiv antigen to receptors on cells of mammals
11/10/1998US5834309 Altering and/or regulating programmed cell death, genetic engineering, codes, expression vectors
11/10/1998US5834307 Recombinant polynucleotide which codes for a polypeptide from a cytomegalovirus glycoprotein; for vaccines, diagnosis
11/10/1998US5834302 Method for producing RNA viruses from CDNA
11/10/1998US5834276 Asparaginyl TRNA synthetase polynucleotides of streptococcus
11/10/1998US5834267 Pure hiv antigen
11/10/1998US5834238 Human GTP binding protein
11/10/1998US5834220 Incubation/complexing with antibodies specific to the cardiac form, forming a ternary complex with troponin c, improved diagnosis of heart attacks
11/10/1998US5834210 Stable troponin subunits and complexes
11/10/1998US5834192 Amino acid sequences, nucleotide sequenes and complements; identified from breast tumor libraries; diagnosing with hybridization complexes; host cells transfected with expression vectors; antisense molecules for treatment
11/10/1998US5834187 Sequence and analysis of LKP pilin structural genes and the LKP pili operon of nontypable Haemophilus influenzae
11/10/1998US5834015 Protein-lipid vesicles and autogenous vaccine comprising the same
11/10/1998US5834001 Methods for making immunoisolatory implantable vehicles with a biocompatiable jacket and a biocompatible matrix core
11/10/1998US5833996 Treatment of psoriasis using dead cells of Mycobacterium vaccae
11/10/1998US5833995 Innoculating with a polypeptide comprising an anigenic portion of the virus stuctural protein
11/10/1998US5833993 Feline immunodeficiency virus vaccine
11/10/1998US5833991 A glycine-rich amino acid sequence is inserted into a fusion protein to prevent an immunogenic response; gene therapy; transfer vectors; vaccines
11/10/1998US5833990 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding peptides
11/10/1998US5833987 Treatment of T cell mediated autoimmune disorders
11/10/1998US5833986 Methods of inhibiting the growth of neoplasia using a monoclonal antibody against α platelet derived growth factor receptor
11/10/1998US5833985 Bispecific molecules for use in inducing antibody dependent effector cell-mediated cytotoxicity
11/10/1998US5833984 Composition and method for preventing and treating inflammation with Immunoglobulin A
11/10/1998US5833983 Interleukin 2 receptor and applications thereof
11/10/1998US5833980 Inoculating poultry, live virus vaccine
11/10/1998US5833975 Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
11/10/1998US5833943 Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody
11/10/1998CA2045649C Attenuated enteroviruses and rhinoviruses
11/07/1998CA2231754A1 A novel human g-protein coupled receptor hcept09
11/07/1998CA2230986A1 Epo primary response gene 1, eprg1
11/05/1998WO1998049561A1 Inhibitors of nuclear protein/nuclear receptor interaction
11/05/1998WO1998049333A2 Eukaryotic gene expression cassette and uses thereof
11/05/1998WO1998049314A2 ANTIGENIC COMPOSITION AND METHOD OF DETECTION FOR $i(HELICOBACTER PYLORI)
11/05/1998WO1998049313A2 Characterization of granulocytic ehrlichia and methods of use
11/05/1998WO1998049312A2 Nucleic acids, proteins, and methods of use of granulocytic erhlichia
11/05/1998WO1998049303A2 Compositions and methods for conferring tick immunity and preventing tick borne diseases
11/05/1998WO1998049296A1 Human cerberus protein
11/05/1998WO1998049294A1 Methods for detecting and reversing resistance to macrocyclic lactone compounds
11/05/1998WO1998049292A2 Polypeptides associated with activator receptors and their biological applications
11/05/1998WO1998049285A1 Polypeptide capable of reacting with antibodies of patients suffering from multiple sclerosis and uses
11/05/1998WO1998049270A1 Cytolytic t-cell clones against colorectal carcinoma and methods of use thereof
11/05/1998WO1998049198A1 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
11/05/1998WO1998049195A1 Corona virus-like particles as tools for vaccination and therapy
11/05/1998WO1998049192A1 SYNTHETIC PEPTIDE CONSTRUCTS FOR THE DIAGNOSIS AND TREATMENT OF PERIODONTITIS ASSOCIATED WITH $i(PORPHYROMONAS GINGIVALIS)
11/05/1998WO1998049135A1 Compounds and compositions for delivering active agents
11/05/1998WO1998048837A1 Polyalkylene oxide-modified single chain polypeptides
11/05/1998WO1998048836A1 Anti-helicobacter vaccine composition comprising a th1 adjuvant
11/05/1998WO1998048835A1 Anti-helicobacter vaccine composition for use by the subdiaphragmatic systemic route, and combined mucosal/parenteral immunization method
11/05/1998WO1998048832A1 Nerve growth factor as a vaccine adjuvant
11/05/1998WO1998048780A1 Vesicular complexes and methods of making and using the same
11/05/1998WO1998048626A1 Methods and compositions for administering dna to mucosal surfaces
11/05/1998WO1998039450A3 Surface protein (spsa protein) of streptococcus pneumoniae, deleted derivatives, expression system for said proteins and vaccine system with said proteins
11/05/1998WO1998039025A3 A composition comprising a carrier and a purified mycobacterial lipid cell-wall component and its use in the prevention, treatment and diagnosis of disease
11/05/1998WO1998034954A3 Ligands for discoidin domain receptor tyrosine kinases and complexes thereof
11/05/1998WO1998033527A3 Cancer immunotherapy with semi-allogeneic cells
11/05/1998WO1998031786A3 Novel microorganisms
11/05/1998WO1998030593A3 Assay of histidine decarboxylase to detect cancer
11/05/1998DE19712541C1 Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen Papillomaviruses means for their detection as well as for the treatment of diseases caused by them
11/05/1998CA2815903A1 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
11/05/1998CA2720332A1 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis